Circulating BRAF(V600E) Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Background: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC) and can be associated with aggressive disease. Previously, a highly sensitive blood RNA-based BRAF(V600E) assay was reported. The objective of this study was to assess the correlation of BRAF(V600E) circulating...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Thyroid
Egile Nagusiak: Lubitz, Carrie C., Zhan, Tiannan, Gunda, Viswanath, Amin, Salma, Gigliotti, Benjamin J., Fingeret, Abbey L., Holm, Tammy M., Wachtel, Heather, Sadow, Peter M., Wirth, Lori J., Sullivan, Ryan J., Panka, David J., Parangi, Sareh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2018
Gaiak:
Thyroid Cancer and Nodules
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865613/
https://ncbi.nlm.nih.gov/pubmed/29378474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0322
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak